Testosterone treatment of clinical hypogonadism in patients with HIV/AIDS.
The use of testosterone to treat clinical symptoms of hypogonadism and wasting among patients with HIV/AIDS is a relatively new area of inquiry and clinical application. Outcome measures have included changes in mood, libido, energy, weight and muscle mass. The purpose of this review is to identify the questions most commonly raised about risks of testosterone therapy, to review available data which address these questions, and to discuss issues of clinical management. These include treatment indications, measurement issues, and side effects and their management.
Rabkin
J G
JG
Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, USA.
Rabkin
R
R
Wagner
G J
GJ
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007006:Hypogonadism / Q000150:complications / Q000188:drug therapy*; D008297:Male; D013739:Testosterone / Q000009:adverse effects / Q000627:therapeutic use*
D013739:Testosterone